Stockreport

Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors